2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome

K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

Standardized team-based care for cardiogenic shock

BN Tehrani, AG Truesdell, MW Sherwood… - Journal of the American …, 2019 - jacc.org
Background: Cardiogenic shock (CS) is a multifactorial, hemodynamically complex
syndrome associated with high mortality. Despite advances in reperfusion and mechanical …

Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association

BJ Geller, SS Sinha, NK Kapur, M Bakitas, LB Balsam… - Circulation, 2022 - Am Heart Assoc
The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

Management and outcomes of cardiogenic shock in cardiac ICUs with versus without shock teams

AI Papolos, BB Kenigsberg, DD Berg, CL Alviar… - Journal of the American …, 2021 - jacc.org
Background Single-center studies suggest that implementation of multidisciplinary
cardiogenic shock (CS) teams is associated with improved CS survival. Objectives The aim …

Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association

TD Henry, MI Tomey, JE Tamis-Holland, H Thiele… - Circulation, 2021 - Am Heart Assoc
Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute
myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded …

Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative

MB Basir, NK Kapur, K Patel, MA Salam… - Catheterization and …, 2019 - Wiley Online Library
Abstract Background The National Cardiogenic Shock Initiative is a single‐arm, prospective,
multicenter study to assess outcomes associated with early mechanical circulatory support …

The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support

AP Amin, JA Spertus, JP Curtis, N Desai, FA Masoudi… - Circulation, 2020 - Am Heart Assoc
Background: Impella was approved for mechanical circulatory support (MCS) in 2008, but
large-scale, real-world data on its use are lacking. Our objective was to describe trends and …

Overview of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the management of cardiogenic shock

A Tsangaris, T Alexy, R Kalra… - Frontiers in …, 2021 - frontiersin.org
Cardiogenic shock accounts for~ 100,000 annual hospital admissions in the United States.
Despite improvements in medical management strategies, in-hospital mortality remains …

[HTML][HTML] Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

NJ Udesen, JE Møller, MG Lindholm, H Eiskjær… - American heart …, 2019 - Elsevier
Objective The DanGer Shock trial test the hypothesis that left ventricular (LV) mechanical
circulatory support with Impella CP transvalvular microaxial flow pump improves survival in …